Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist.
TNF-alpha and lymphotoxin are proinflammatory cytokines that are non-homologous in sequence, have similar homotrimeric structure and they exert their biological activity by aggregating two types of shared cell surface receptors. The natural inhibitors of TNF and lymphotoxin are the shed extracellula...
Auteurs principaux: | Neve, R, Kissonerghis, M, Clark, J, Feldmann, M, Chernajovsky, Y |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
1996
|
Documents similaires
-
Comparison of patterns of expression of tumour necrosis factor, lymphotoxin and interleukin-6 mRNA.
par: Turner, M, et autres
Publié: (1988) -
HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin.
par: Pujol-Borrell, R, et autres
Publié: (1987) -
Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
par: Corcoran, A, et autres
Publié: (1994) -
Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents.
par: Foxwell, B, et autres
Publié: (2003) -
Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations.
par: Clark, T, et autres
Publié: (2009)